Whereas, according to the Centers for Disease Control and Prevention (referred to in this preamble as the CDC )— (1) an estimated 37,300,000 individuals in the United States have diabetes; and (2) an estimated 96,000,000 individuals in the United States who are 18 years of age or older have prediabetes; Whereas diabetes is a serious chronic condition that affects individuals of every age, race, ethnicity, and income level; Whereas the CDC reports that— (1) Hispanic, Black, Asian, American Indian, and Alaska Native adults in the United States are disproportionately affected by diabetes and develop the disease at much higher rates than the general population of the United States; and (2) an estimated 23 percent of individuals with diabetes in the United States have not yet been diagnosed with the disease; Whereas, in the United States, an estimated 11.3 percent of the population, including 29.2 percent of individuals who are 65 years of age or older, have diabetes; Whereas, of the approximately 16,200,000 veterans in the United States, 1 in 4 are receiving care for diabetes from the Department of Veterans Affairs; Whereas the risk of developing type 2 diabetes at some point in life is 40 percent for adults in the United States; Whereas, according to the American Diabetes Association— (1) in 2022, the estimated direct and indirect medical costs in the United States for cases of diagnosed diabetes was $412,900,000,000; and (2) as insulin prices rise, 1 in 4 individuals using insulin report reducing use due to insulin cost; Whereas the American Diabetes Association reports that, in 2017, care for individuals with diagnosed diabetes accounted for 1 in 4 health care dollars in the United States; Whereas the cost of health care is estimated to be 2.6 times higher for individuals in the United States with diabetes than those without diabetes; Whereas, as of November 2023, a cure for diabetes does not exist; Whereas there are successful means to reduce the incidence, and delay the onset, of type 2 diabetes